Evidence map›Paper›PMID 38689986›Full record

ArticleHeliyon2024

Patients' knowledge about the uses, risks, and beliefs surrounding the regulation and safety of

José F Ramírez-Méndez, Pedro Wong-Salgado, Peter Gámez, Pedro Solis, Jeel Moya-Salazar

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

José F Ramírez-MéndezCANNAVITAL Clínica Especializada en Terapias con Cannabinoides, Lima, Peru.
Pedro Wong-SalgadoCANNAVITAL Clínica Especializada en Terapias con Cannabinoides, Lima, Peru.
Peter GámezCANNAVITAL Clínica Especializada en Terapias con Cannabinoides, Lima, Peru.
Pedro SolisGraduate School, Universidad Alas Peruanas, Lima, Peru.
Jeel Moya-SalazarDigital Transformation Center, Universidad Norbert Wiener, Lima, Peru.
Centro Peruano de Estudios Sociales · PEEsSALUD · PEUniversidad Alas Peruanas · PEUniversidad Norbert Wiener · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent decades, there has been a significant rise in the utilization of medical cannabis. Understanding the various facets surrounding its usage and regulation is paramount for patients, health professionals, and policymakers. This cross-sectional study conducted at the CANNAVITAL clinic in Lima, Peru aimed to assess the basic knowledge, attitudes towards use, and beliefs regarding regulation and safety of

Indexed as

AssessmentCannabisKnowledgeMarijuanaMedical marijuanaPeruSurvey

Identifiers

PMID38689986
PMCPMC11059411
OpenAlexW4393047373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.